Jeffrey R. Koup - Concepedia

Author

Jeffrey R. Koup

Also Known As

J KOUP, J Koup, J R Koup, J. Koup, J. R. Koup, J.R. Koup, JEFFREY R. KOUP, Jeffrey Koup, Jeffrey R Koup, Jeffrey R. Koup

117

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

University of Washington University at Buffalo, State University of New York Seattle Children's Hospital Seattle University Applied Dynamics International (United States)

About

Jeffrey R. Koup is an author at University of Washington specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	40	1.9K
2	Health Sciences	2	2	23
3	Public Health	2	2	46
4	Engineering	1	1	17
5	Natural Sciences	1	1	27

Jeffrey R. Koup

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol William J. Jusko, Mark Gardner, Antoinette Mangione, Journal of Pharmaceutical Sciences Substance AbuseOral ContraceptivesMedicineTheophylline ClearancesPharmacotherapy	1979	251
Altered Theophylline Clearance During an Influenza B Outbreak Michael J. Kraemer, Clifton T. Furukawa, Jeffrey R. Koup, PEDIATRICS AsthmaKing CountyAllergyInfluenza BAllergy Medicine	1982	198
Digoxin pharmacokinetics: Role of renal failure in dosage regimen design Jeffrey R. Koup, William J. Jusko, Charles M. Elwood, Clinical Pharmacology & Therapeutics	1975	128
Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled study Jack Lévy, Arnold L. Smith, Jeffrey R. Koup, The Journal of Pediatrics MedicinePathologyAntibiotics	1984	126
Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses Jeffrey R. Koup, David J. Greenblatt, William J. Jusko, Journal of Pharmacokinetics and Biopharmaceutics Normal SubjectsIntravenous BolusMedicineInfusion DosesClinical Pharmacology	1975	125
Theophylline pharmacokinetics in premature infants with apnea George P. Giacoia, William J. Jusko, James A. Menke, The Journal of Pediatrics Theophylline PharmacokineticsNeonatologyPediatric Lung DiseasePediatrics	1976	96
Pharmacokinetic-Pharmacodynamic Modeling of Biomarker Response and Tumor Growth Inhibition to an Orally Available cMet Kinase Inhibitor in Human Tumor Xenograft Mouse Models Shinji Yamazaki, Judith Skaptason, David Romero, Drug Metabolism and Disposition	2008	94
Nonlinear assessment of phenytoin bioavailability William J. Jusko, Jeffrey R. Koup, Gunnar Alván Journal of Pharmacokinetics and Biopharmaceutics BiochemistryMedicineBioanalysisNonlinear AssessmentPharmacology	1976	92
Pharmacokinetic concepts ? Drug binding, apparent volume of distribution and clearance M. Gibaldi, Jeffrey R. Koup European Journal of Clinical Pharmacology Pharmacokinetic ModelingPharmacodynamicsPharmacokinetic ConceptsMedicineApparent Volume	1981	91
Pharmacokinetics of ciprofloxacin in cystic fibrosis Robin L. Davis, Jeffrey R. Koup, Judy Williams‐Warren, Antimicrobial Agents and Chemotherapy FibrosisRandomized Crossover SequenceAntibioticsChronic Kidney DiseasePharmacology	1987	85

Page 1